Medical Pharmacology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Division of Pharmacology, School of Pharmacy, Cardiff University, Cardiff, United Kingdom.
Eur J Pharmacol. 2024 Oct 15;981:176895. doi: 10.1016/j.ejphar.2024.176895. Epub 2024 Aug 15.
Substantial evidence indicates trace amines can induce vasoconstriction independently of noradrenaline release. However, the mechanism underlying noradrenaline-independent vasoconstrictor responses to trace amines has not yet been established. This study evaluates the role of trace amine-associated receptor 1 (TAAR1) and other biogenic amine receptors in mediating β-phenylethylamine and the TAAR-1 selective agonist RO5256390-induced vasoconstriction.
Vasoconstrictor responses to β-PEA and the TAAR1-selective agonist, RO5256390 were assessed in vitro in endothelium-denuded aortic rings and third-order mesenteric arteries of male Sprague Dawley rats.
β-PEA and RO5256390 induced concentration-dependent vasoconstriction of aortic rings but not third-order mesenteric arteries. Vasoconstrictor responses in aortic rings were insensitive to antagonists of 5-HT. The murine-selective TAAR1 antagonist, EPPTB, had no effect on either β-PEA or RO5256390-induced vasoconstriction. The α-adrenoceptor antagonist, prazosin, and the α-adrenoceptor antagonist, yohimbine, induced a shift of the β-PEA concentration response curve too small to be ascribed to antagonism of α-or α-adrenoceptors, respectively. The α-adrenoceptor antagonist atipamezole had no effect on β-PEA or RO5256390-induced vasoconstriction.
Vasoconstrictor responses to trace amines are not mediated by classical biogenic amine neurotransmitter receptors. Insensitivity of β-PEA vasoconstrictor responses to EPPTB, may be explained by its low affinity for rat rather than murine TAAR1. Therefore, TAAR1 remains the most likely candidate receptor mediating vasoconstrictor responses to trace amines and that prazosin and yohimbine have low affinity for TAAR1.
大量证据表明,痕量胺可独立于去甲肾上腺素释放引起血管收缩。然而,痕量胺引起的去甲肾上腺素非依赖性血管收缩反应的机制尚未确定。本研究评估了痕量胺相关受体 1(TAAR1)和其他生物胺受体在介导β-苯乙胺和 TAAR1 选择性激动剂 RO5256390 诱导的血管收缩中的作用。
在雄性 Sprague Dawley 大鼠去内皮的主动脉环和第三级肠系膜动脉中,评估β-PEA 和 TAAR1 选择性激动剂 RO5256390 的体外血管收缩反应。
β-PEA 和 RO5256390 诱导主动脉环产生浓度依赖性血管收缩,但对第三级肠系膜动脉无作用。主动脉环的血管收缩反应对 5-HT 拮抗剂不敏感。对鼠选择性 TAAR1 拮抗剂 EPPTB 对β-PEA 或 RO5256390 诱导的血管收缩均无影响。α-肾上腺素受体拮抗剂哌唑嗪和α-肾上腺素受体拮抗剂育亨宾分别引起β-PEA 浓度反应曲线的移位太小,不能归因于对α-或α-肾上腺素受体的拮抗作用。α-肾上腺素受体拮抗剂阿替美唑对β-PEA 或 RO5256390 诱导的血管收缩无影响。
痕量胺的血管收缩反应不是由经典的生物胺神经递质受体介导的。EPPTB 对β-PEA 血管收缩反应的不敏感性可能与其对大鼠而不是鼠 TAAR1 的低亲和力有关。因此,TAAR1 仍然是介导痕量胺引起的血管收缩反应的最可能候选受体,并且哌唑嗪和育亨宾对 TAAR1 的亲和力较低。